Current projects

  • Approval and regulation of medications and devices in children

  • Industry ties and conflicts of interest in drug reviews and meta-analyses

  • Transparency and reporting of clinical trials in pediatric populations

  • Opioid use among children treated in ambulatory settings

  • Impact of Prescription Drug Monitoring Programs on pediatric opioid poisonings and overdoses

  • Discontinuation and non-publicaiton of clinical trials for rare diseases in children

  • Translation of published research findings into clinical practice

  • Completion and publication of FDA-mandated pediatric trials